References
- Naclerio R M., Meier H L., Kagey‐Sobotka A, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983; 128: 597–602
- Zeiger R S. Allergic and nonallergic rhinitis: classification and pathogenesis Part I. Allergic rhinitis. Am J Rhinol 1989; 3: 21–47
- Wang D Y., Clement P, Smitz J, Derde M ‐P. Concentrations of chemical mediators in the nasal secretions after nasal allergen challenge in atopic patients. Eur Arch Otorhinolaryngol 1993, (in press)
- Biewenga J, Stoop A E., Baker H E., et al. Nasal secretions from patients with polyps and healthy individuals, collected with a new aspiration system: evaluation of total protein and immunoglobulin concentrations. Ann Clin Biochem 1991; 28: 260–6
- Gerth Van Wijk R, Diegcs P H. Comparison of nasal responsiveness to histamine, methacholine and phento‐lamine in allergic rhinitis patients and controls. Clinical Allcrgy 1987; 17: 563–70
- Raphael G D., Igarashi Y, White M V., Kaliner M A. The pathophysiology of rhinitis. J Allergy Clin Immunol 1991; 88: 33–42
- Gleich J G. The late phase of the immunoglobulin E‐mediated reaction: a link between anaphylaxis and common allergic disease. J Allergy Clin lmmunol 1982; 70: 170–7
- Naclcrio R M., Proud D, Peters S P., et al. Inflammatory mediators in nasal secretions during induced rhinitis. Clin Allergy 1986; 16: 101–10
- Wachs M, Proud D, Lichtenstcin L M., Kagey‐Sobotka A, Norman P S., Naclerio R M. Observations on the pathogenesis of nasal priming. J Allergy Clin lmmunol 1989; 84: 492–501
- Juliusson S, Holmberg K, Baumgarten C R., Olsson M, Enander I, Pipkorn U. Tryptase in nasal lavage fluid after local allergen challenge. Allergy 1991; 46: 459–65
- Bisgaard H, Grønborg H, Mygind N, Dahl R, Lindqvist N, Venge P. Allergen‐induced increase of eosinophil cationic protein in nasal lavage fluid: effect of the glucocorticoid budesonidc. J Allergy Clin lmmunol 1990; 85: 891–5
- Nishioka K, Saito C, Nagano T, Okano M, Masuda Y, Kuriyama T. Eosinophil cationic protein in the nasal secretions of patients with mite allergic rhinitis. Laryngoscope 1993; 103: 189–92
- Svensson C, Anderson M, Persson C G A, Venge P, Alkner U, Pipkorn U. Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol 1990; 85: 828–33
- Rasp G, Hochstrasser K. Tryptase in nasal fluid is a useful marker of allergic rhinitis. Allergy 1993; 48: 72–4
- Proud D, Bailey G S., Naclerio R M., et al. Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allcrgcn. cold, dry air, and hyperosmolar solutions. J Allergy Clin Immunol 1992; 89: 1098–110
- Linder A, Strandberg K, Deuschl H. Variations in histamine concentration in nasal secretions with allergic rhinitis. Allergy 1988; 43: 119–26
- Dorsch W, Strasser Th. Leukotrienes. Late phase allergic reactions, W Dorsch. CRC Press, Florida 1990; 59–64
- Vengc P, Håkansson L, Rak S, Dahl R, Fredens K. Inflammatory cells in asthma an rhinitis. Rhinitis and asthma, N Mygind, U. Pipkorn, R Dahl. Munksgaard, Copenhagen 1990; 188–202